The document discusses blood groups, blood transfusions, and organ transplants. It explains that blood is grouped into types based on the presence or absence of antigens (A, B, Rh). Compatible blood must be used in transfusions to avoid reactions. O blood can be donated universally while AB recipients can receive any type. Organ transplant rejection occurs unless immunosuppressive drugs prevent the immune system from attacking foreign tissues. Matching donors and recipients based on human leukocyte antigens reduces rejection risks.
• A blood group also called a Blood Type.
• Classification of blood is based on the presence or absence
of inherited antigenic substances on the surface of red blood
cells (RBCs).
• These antigens may be proteins, carbohydrates,
glycoproteins, or glycolipids, depending on the blood group
system.
• A blood group also called a Blood Type.
• Classification of blood is based on the presence or absence
of inherited antigenic substances on the surface of red blood
cells (RBCs).
• These antigens may be proteins, carbohydrates,
glycoproteins, or glycolipids, depending on the blood group
system.
Hematopoiesis: Origin and development of blood cellsVarun Singh
The process of hematopoiesis, its microenvironment and regulators. the process of erythropoiesis, myelopoiesis and megakaryopoiesis and their regulators with illustrated figures.
Blood grouping and transfusion reactions.pptxRekhaSenthil2
Describes about the grouping and typing of blood groups. bombay blood group is explained in detail
erythroblastosis fetalis is explained in detail.. mismatched transfusion reactions are well explained
Hematopoiesis: Origin and development of blood cellsVarun Singh
The process of hematopoiesis, its microenvironment and regulators. the process of erythropoiesis, myelopoiesis and megakaryopoiesis and their regulators with illustrated figures.
Blood grouping and transfusion reactions.pptxRekhaSenthil2
Describes about the grouping and typing of blood groups. bombay blood group is explained in detail
erythroblastosis fetalis is explained in detail.. mismatched transfusion reactions are well explained
blood transfusion is a life saving procedure. so role of nurse here while transfused the blood in the ward is important. in this slide role of nurse is given here. if you like kindly give your comment and share it to others. follow my account to know more.
Common medication used for anesthesia, there action; dosage; adverse effect; duration of action.
They Include {inhalation + Induction + Muscle relaxant + Anticholinergic + Analgesic + Resuscitation}
in this presentation lecture we gone take a hypo and hyper thyrodism that affect the human cell because both situation may increase or decrease the basal metabolic rate.
When the pituitary Gland it' s function is increased whether the cause are?
Both anterior and Posterior gland secretions are increased the most causes are ADENOMAS
in this presentation you will be learn the different drug form that all medical health workers prescribing the medication.
the medical student should have a good knowledge and keep in mind these drug forms based on medical administration the drugs are classified into invasive (injection and transdermal implantation) and non invasive (oral, inhalers, suppository)
Medical equipment and tools are crucial to saving a person's life or performing any procedure.
i presented here the most and commonly equipment used by medical student to improve their skills
This note paper is short notes of general physiology for medical students who which to understand the concept of the physiology, physiology is the mother of medicine.
A summary of skeletal muscle contraction and relaxationAyub Abdi
it consist for 4 pages and cover all the steps that occur during muscle contraction and relaxation, I does not take a time just 5 minute is enough to read. I hope it's interesting.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
2. • When blood from two individuals is mixed,
sometimes clumping (agglutination) of RBCs
occurs.
• This clumping is because of the immunological
reactions.
• Two particular types of antigens are much more
likely than the others to cause blood transfusion
reactions.
• They are the O-A-B system of antigens and the Rh
system.
3. 1- ABO BLOOD GROUPS:
• Based on the presence or absence of antigen
A and antigen B, blood is divided into four
groups:
1. ‘A’ group
2. ‘B’ group
3. ‘AB’ group
4. ‘O’ group.
4.
5. IMPORTANCE OF ABO GROUPS
IN BLOOD TRANSFUSION
• The one who gives blood is called the donor.
• the one who receives the blood is called recipient.
• O’ group blood can be given to any blood group
persons and the people with this blood group are
called universal donors.
• People with AB group can receive blood from any
blood group persons are called universal recipients.
• whether the person’s body will accept the donor’s
blood or not are called cross – matching.
• To determine the blood group of a person are called
blood matching.
6. TRANSFUSION REACTIONS
DUE TO ABO INCOMPATIBILITY:
• Transfusion reactions are the adverse reactions in the body,
which occur due to transfusion error that involves transfusion of
incompatible (mismatched) blood.
• The reactions may be mild causing only fever and hives (skin
disorder characterized by itching) or may be severe leading to
renal failure, shock and death.
• In mismatched transfusion, the transfusion reactions occur
between donor’s RBC and recipient’s plasma.
• if the donor’s plasma contains agglutinins against recipient’s
RBC, agglutination does not occur because these antibodies are
diluted in the recipient’s blood.
• But, if recipient’s plasma contains agglutinins against donor’s
RBCs, the immune system launches a response against the new
blood cells. Donor RBCs are agglutinated resulting in transfusion
reactions.
7. • Cause for Transfusion Reactions:
• The recipient’s antibodies (IgG or IgM) adhere to the
donor RBCs, which are agglutinated and destroyed.
• Signs and Symptoms of Transfusion Reactions:
1- Non-hemolytic transfusion reaction:
• few minutes to hours after the commencement of
blood transfusion.
• Common symptoms are fever, difficulty in breathing
and itching.
2- Hemolytic transfusion reaction:
• may be acute or delayed.
8. • The acute hemolytic reaction:
• few minutes of transfusion.
• rapid hemolysis of donor’s RBCs.
• Symptoms include:
1. Fever, chills, increased heart rate, low blood pressure, shortness of
breath, bronchospasm, nausea, vomiting, red urine, chest pain, back
pain and rigor.
2. Pulmonary edema and congestive cardiac failure.
• The Delayed hemolytic reaction:
• 1 to 5 days after transfusion.
• release of large amount of hemoglobin into the plasma.
• Symptoms and sign include:
1. Jaundice
2. Cardiac Shock
3. Renal Shutdown
9. 2- Rh FACTOR:
• Rh factor is an antigen present in RBC.
• This antigen was discovered by Landsteiner and Wiener.
• It was first discovered in Rhesus monkey.
• There are many Rh antigens but only the D antigen is more
antigenic in human.
• The persons having D antigen are called ‘Rh positive’.
• Those without D antigen are called ‘Rh negative’.
• The antigen D does not have corresponding natural
antibody (anti-D).
• If Rh positive blood is transfused to a Rh negative person
anti-D is developed in that person.
10.
11. TRANSFUSION REACTIONS DUE
TO Rh INCOMPATIBILITY:
HEMOLYTIC DISEASE OF FETUS AND
NEWBORN – ERYTHROBLASTOSIS
FETALIS:
The difference between the Rh
blood group of the mother and baby.
Erythroblastosis fetalis is a disorder in
fetus, characterized by the presence of
erythroblasts in blood.
at the time of parturition (delivery of the
child), the Rh antigen from fetal blood
may leak into mother’s blood because of
placental detachment.
Ultimately due to excessive hemolysis
severe complications develop, viz.
1. Severe anemia
2. Hydrops fetalis
3. Kernicterus
12.
13.
14. OTHER BLOOD GROUPS:
• In addition to ABO blood groups and Rh factor, many more blood group systems
were found, such as:
1. Lewis blood group.
2. MNS blood groups.
3. Others:
i. Auberger groups
ii. Diego group
iii. Bombay group
iv. Duffy group
v. Lutheran group
vi. P group
vii. Kell group
viii. I group
ix. Kidd group
x. Sulter Xg group.
• However, these systems of blood groups do not have much clinical importance.
15. IMPORTANCE OF KNOWING
BLOOD GROUP:
1. Medically, it is important during blood transfusions
and in tissue transplants.
2. Socially, one should know his or her own blood
group and become a member of the Blood Donor’s
Club so that he or she can be approached for blood
donation during emergency conditions.
3. It general among the couples, knowledge of blood
groups helps to prevent the complications due to Rh
incompatibility and save the child from the disorders
like erythroblastosis fetalis.
4. Judicially, it is helpful in medico-legal cases to sort
out parental disputes.
16.
17.
18. • Blood transfusion: is the process of
transferring blood or blood components from
one person (the donor) into the bloodstream
of another person (the recipient).
• Transfusion is done as a life-saving procedure
to replace blood cells or blood products lost
through bleeding.
19. CONDITIONS WHEN BLOOD
TRANSFUSION IS
NECESSARY:
1. Anemia.
2. Hemorrhage.
3. Trauma.
4. Burns.
5. Surgery.
PRECAUTIONS TO BE TAKEN BEFORE
THE TRANSFUSION OF BLOOD
1. Donor must be healthy,
without any diseases like:
a. Sexually transmitted
diseases such as syphilis
b. Diseases caused by virus like
hepatitis, AIDS, etc.
2. Only compatible blood must
be transfused
3. Both matching and cross-
matching must be done
4. Rh compatibility must be
confirmed.
20. HAZARDS OF BLOOD
TRANSFUSION:
1. Reactions due to
mismatched (incompatible)
blood transfusion –
transfusion reactions
2. Reactions due to massive
blood transfusion
3. Reactions due to faulty
techniques during blood
transfusion
4. Transmission of infections.
BLOOD SUBSTITUTES
• Fluids infused into the body
instead of whole blood are
known as blood substitutes.
• Commonly used blood
substitutes are:
1. Human plasma
2. 0.9% sodium chloride solution
(saline) and 5% glucose
3. Colloids like gum acacia,
isinglass, albumin and animal
gelatin.
21. EXCHANGE TRANSFUSION
• Exchange transfusion is the
procedure which involves
removal of patient’s blood
completely and replacement
with fresh blood or plasma of
the donor.
• It is otherwise known as
replacement transfusion.
• It is an important life-saving
procedure carried out in
conditions such as severe
jaundice, sickle cell anemia,
erythroblastosis fetalis, etc.
AUTOLOGOUS BLOOD
TRANSFUSION:
• Autologous blood transfusion is the
collection and
• reinfusion of patient’s own blood. It
is also called self blood donation.
• The conventional transfusion of
blood that is collected from persons
other than the patient is called
allogeneic or heterologous blood
transfusion.
• Autologous blood transfusion is used
for planned surgical procedures.
Patient’s blood is withdrawn in
advance and stored. Later, it is
infused if necessary during surgery.
• This type of blood transfusion
prevents the transmission of viruses
such as HIV or hepatitis B. It also
eliminates transfusion reactions.
22.
23.
24. • Each bodily tissue has its
own additional
complement of antigens.
• Foreign cells transplanted
anywhere into the body
of a recipient can
produce immune
reactions.
• Most recipients are just
as able to resist invasion
by foreign tissue cells as
to resist invasion by
foreign bacteria or RBCs.
25.
26. Autografts, Isografts, Allografts, and
Xenografts:
• Autograft: transplant of a tissue or whole organ
from one part of the same animal to another
part.
• Isograft: from one identical twin to another.
• Allograft: from one human being to another or
from any animal to another animal of the same
species.
• Xenograft: from a non-human animal to a
human being or from an animal of one species
to one of another species.
27. Transplantation of Cellular
Tissues:
• In the case of autografts and isografts, cells in the
transplant contain virtually the same types of antigens as in
the tissues of the recipient and will almost always continue
to live normally and indefinitely if an adequate blood
supply is provided.
• At the other extreme, immune reactions almost always
occur in xenografts, causing death of the cells in the graft
within 1 day to 5 weeks after transplantation unless some
specific therapy is used to prevent the immune reactions.
• Organ that can be transplanted are:
• skin, kidney, heart, liver, glandular tissue, bone marrow,
and lung.
• Duration of these organ transplanted is kidney (5 to 15
years), and liver and heart transplants for (1 to 15 years).
28. • The most important antigens for causing graft rejection are a
complex called the human leukocyte antigen (HLA) antigens.
• Prevention of Graft Rejection by Suppressing the Immune
System:
1. Glucocorticoid hormones which inhibit genes that code for
several cytokines, inhibit T-cell proliferation and antibody
formation.
2. Various drugs that have a toxic effect on the lymphoid system
and, therefore, block formation of antibodies and T cells,
especially the drug azathioprine.
3. Cyclosporine and tacrolimus, which inhibit formation of T-
helper cells and, therefore, are especially efficacious in blocking
the T-cell rejection reaction.
• These agents have proved to be highly valuable drugs because
they do not depress some other portions of the immune
system.
4. Immunosuppressive antibody therapy, including specific
antilymphocyte or IL-2 receptor antibodies.